Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06677996 · ClinicalTrials.gov registry record · Phase 1
A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants
A Phase 1 study, sponsored by Immunome.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT06677996 is a Phase 1 study that has completed, run by Immunome. The registered enrollment target is 22 participants.
The verdict
NCT06677996, a Phase 1 study, has completed, sponsored by Immunome.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
This is an open label, fixed sequence, 1-way crossover drug-drug interaction (DDI) study in healthy participants.
Interventions
- DRUG varegacestat
- DRUG Itraconazole (200 mg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2024-11-11 |
| Est. Completion | 2025-05-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06677996
The ClinicalTrials.gov registry entry for NCT06677996 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Immunome, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which varegacestat is the first listed.
NCT06677996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06677996 about?
NCT06677996 is a clinical study titled "A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants". This is an open label, fixed sequence, 1-way crossover drug-drug interaction (DDI) study in healthy participants.
What is the current status of trial NCT06677996?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2024-11-11. Estimated completion is 2025-05-07.
What interventions are being tested in trial NCT06677996?
The interventions under investigation include: varegacestat (DRUG), Itraconazole (200 mg) (DRUG).
Who is sponsoring clinical trial NCT06677996?
This trial is sponsored by Immunome, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.